Osiris/Genzyme Anticipates Approval Of Stem Cell Therapy Prochymal By 2010

Osiris begins the FDA submission process for its mesenchymal stem cell therapy Prochymal this quarter, making a late-2009 approval of the world's first stem cell therapy a possibility if the agency grants a six-month review, and a first-cycle approval